135 related articles for article (PubMed ID: 11309652)
1. Functional interleukin-4 receptor and interleukin-2 receptor common gamma chain in human gastric carcinoma: a possible mechanism for cytokine-based therapy.
Essner R; Huynh Y; Nguyen T; Rose M; Kojima M; Hoon DS
J Gastrointest Surg; 2001; 5(1):81-90. PubMed ID: 11309652
[TBL] [Abstract][Full Text] [Related]
2. Functional interleukin 4 receptor and interleukin 2 receptor common gamma-chain on human non-small cell lung cancers: novel targets for immune therapy.
Essner R; Huynh Y; Nguyen T; Morton DL; Hoon DS
J Thorac Cardiovasc Surg; 2000 Jan; 119(1):10-20. PubMed ID: 10612755
[TBL] [Abstract][Full Text] [Related]
3. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway.
Murata T; Husain SR; Mohri H; Puri RK
Int Immunol; 1998 Aug; 10(8):1103-10. PubMed ID: 9723696
[TBL] [Abstract][Full Text] [Related]
4. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.
Murata T; Obiri NI; Puri RK
Int J Cancer; 1997 Jan; 70(2):230-40. PubMed ID: 9009165
[TBL] [Abstract][Full Text] [Related]
5. Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system.
Murata T; Taguchi J; Puri RK; Mohri H
Int J Hematol; 1999 Jan; 69(1):13-20. PubMed ID: 10641437
[TBL] [Abstract][Full Text] [Related]
6. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.
Murata T; Noguchi PD; Puri RK
J Biol Chem; 1995 Dec; 270(51):30829-36. PubMed ID: 8530527
[TBL] [Abstract][Full Text] [Related]
7. Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells.
Schumann RR; Nakarai T; Gruss HJ; Brach MA; von Arnim U; Kirschning C; Karawajew L; Ludwig WD; Renauld JC; Ritz J; Herrmann F
Blood; 1996 Mar; 87(6):2419-27. PubMed ID: 8630406
[TBL] [Abstract][Full Text] [Related]
8. Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Nakamura M; Van Snick J; Sugamura K
Eur J Immunol; 1996 Jun; 26(6):1322-7. PubMed ID: 8647212
[TBL] [Abstract][Full Text] [Related]
9. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL
Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
Reichert TE; Nagashima S; Kashii Y; Stanson J; Gao G; Dou QP; Whiteside TL
Oncogene; 2000 Jan; 19(4):514-25. PubMed ID: 10698521
[TBL] [Abstract][Full Text] [Related]
11. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
12. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling.
Murata T; Noguchi PD; Puri RK
J Immunol; 1996 Apr; 156(8):2972-8. PubMed ID: 8609418
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2.
Yasumura S; Lin WC; Weidmann E; Hebda P; Whiteside TL
Int J Cancer; 1994 Oct; 59(2):225-34. PubMed ID: 7523315
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IL-2 signaling.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Sugamura K
Leukemia; 1997 Apr; 11 Suppl 3():416-7. PubMed ID: 9209410
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction of interleukin 2 in human natural killer cells: involvement of the p56lck tyrosine kinase.
Vitte-Mony I; Delespine-Carmagnat M; Bertoglio JH
Mol Immunol; 1994 Jun; 31(8):623-32. PubMed ID: 7910947
[TBL] [Abstract][Full Text] [Related]
16. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
Kawakami K; Leland P; Puri RK
Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
[TBL] [Abstract][Full Text] [Related]
17. T-lymphocyte proliferation: tyrosine kinases in interleukin 2 signal transduction.
Schmandt R; Fung M; Arima N; Zhang N; Leung B; May C; Gibson S; Hill M; Green W; Mills GB
Baillieres Clin Haematol; 1992 Jul; 5(3):551-73. PubMed ID: 1457964
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors.
Murata T; Taguchi J; Puri RK
Blood; 1998 May; 91(10):3884-91. PubMed ID: 9573026
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
[TBL] [Abstract][Full Text] [Related]
20. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
